Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00395135
Status:
COMPLETED
Last Update Posted:
2019-10-02
First Post:
2006-10-31
Brief Title:
BLOOM Behavioral Modification and Lorcaserin for Overweight and Obesity Management
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
BLOOM Behavioral Modification and Lorcaserin for Overweight and Obesity Management A 104-Week Double-blind Randomized Placebo-controlled Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients
Status:
COMPLETED
Status Verified Date:
2013-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the first year of treatment Week 52 and to assess the ability of lorcaserin to maintain weight loss at the end of the second year of treatment Week 104
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None